| abstract |
(5R) -1,5-diaryl-4,5-dihydro-1H-pyrazole-3-carboxamidine derivatives as cannabinoid-CB 1 receptor antagonists; Methods of preparing these compounds; Novel intermediates useful for the synthesis of said dihydropyrazole derivatives; Methods of making these intermediates; Pharmaceutical compositions containing one or more of these dihydropyrazole derivatives as active ingredients, as well as the use of these pharmaceutical compositions for treating psychiatric and neurological disorders associated with cannabinoid receptors. The compound is a compound of formula (I). Formula I In the above formula (I) Radicals have the meanings described in the specification. |